Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
117106-20-4
146346-88-5
159610-93-2
1654740-73-4
166108-71-0
204320-51-4
415697-57-3 | 2-Bromo-N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)benzenesulfonamide | AA019EIJ | MFCD30185863
883501-73-3 | Methyl 3-(2-aminothiazol-5-yl)propanoate | AA019EM6 | MFCD06245783
1134898-77-3 | 6-(3,5-Dimethyl-1H-pyrazol-1-yl)nicotinonitrile | AA019EOY | MFCD09948772
170837-78-2 | tert-Butyl 4-(2-(2-hydroxyethyl)phenyl)piperidine-1-carboxylate | AA019ES7 | MFCD30099263
898128-02-4 | 1,3-Dibromo-5-fluoro-2-nitrobenzene | AA019EVI | MFCD07657519
14565-11-8 | Methyl 7-hydroxyheptanoate | AA019EYC | MFCD16039616
16960-16-0 | Tetracosactide | AA019FRZ | MFCD00167476
1416323-31-3 | 3-Ethynyl-3-ethyloxetane-E8501 | AA019G5Z | MFCD22628736
380341-89-9 | 2,4-dichloro-5-[(5-chloro-2,4-dimethoxyphenyl)sulfamoyl]benzoic acid | AA019GIS | MFCD02725162
380346-57-6 | 2-chloro-N-(2,4,6-triiodophenyl)acetamide | AA019GTO | MFCD02725651